Endoscopic sphincteropapillotomy combined with balloon dilation for cirrhosis accompanied with choledocholithiasis
10.3760/cma.j.issn.1007-5232.2014.12.006
- VernacularTitle:内镜下乳头括约肌小切开联合球囊扩张术治疗肝硬化合并胆总管结石的疗效观察
- Author:
Xianbin ZHOU
;
Liping YE
;
Yu ZHANG
;
Minhua LIN
;
Lingyan SHEN
;
Xinrong JI
;
Saiqin HE
- Publication Type:Journal Article
- Keywords:
Cirrhosis of liver;
Choledocholith;
Therapeutic endoscopy;
Endoscopic sphincteropapillotomy;
Endoscopic papillary balloon dilation
- From:
Chinese Journal of Digestive Endoscopy
2014;31(12):708-712
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the clincial effectiveness and safety of endoscopic sphincteropapillotomy combined with balloon dilation for decompensated cirrhosis accompanied with choledocholithiasis.Methods Data of 79 cases of decompensated cirrhosis patients with choledocholithiasis who underwent limited endoscopic sphincterotomy plus endoscopic papillary balloon dilation (ESBD,the ESBD group) and 42 cases who underwent endoscopic papillary balloon dilation(EPBD,the EPBD group)were retrospectively analysed and compared for complete stone clearance rate,one-time stone clearance rate and complications.Results The rate of complete stone clearance and one-time stone clearance were 94.9％ (75/79) and 77.2％ (61/79)in ESBD group,and those were 88.1％ (37/42) and 59.5％ (25/42) in EPBD group respectively.The rate of complete stone clearance was a little higher in ESBD group than that in EPBD group.In ESBD group,ERCP-related bleeding occurred in 3 patients (3.8％),post-ERCP hyperamylasemia in 3 (3.8％)and post-ERCP pancreatitis in 2 (2.5％) ; while in EPBD group,post-ERCP hyperamylasemia occurred in 8 patients(19.0％),post-ERCP pancreatitis in 6(14.3％) and ERCP-related bleeding did not occur.There were no significant difference in ERCP-related bleeding between ESBD group and EPBD group (P =0.551).However,the rates of post-ERCP pancreatitis and hyperamylasemia in ESBD group were significantly lower than those in EPBD group(P ＜ 0.05).Conclusion ESBD is a safe and effective procedure for choledocholithiasis accompanied by decompensated cirrhosis,with several advantages over EPBD in terms of higher one-time stone clearance rate,reduced risk of post-ERCP pancreatitis and hyperamylasemia,and without noticeable increase in the risk of bleeding related to ERCP.
